發表論文目錄

  1. Huang SF, Huang YC, Chang FY, Lin JC, Chiu CH, Chen CW, Wang FD, Chiu YL, Cheng SH, Cheng CY, Lin YC, Chen CP, Huang CH, Liu PY, Lee YT, Lee CH, Chen YS, Sy CL, Tseng YT, Hsu CT, Tseng CC, Lee YL, Liu CE, Sytwu HK., Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan. Biomed J. 2020 May 29; doi: 10.1016/j.bj.2020.05.018  3.697
  2. Du PX, Chou YY, Santos HM, Keskin BB, Hsieh MH, Ho TS, Wang JY, Lin YL, Syu GD. Development and Application of Human Coronavirus Protein Microarray for Specificity Analysis. Anal Chem. 2021 Jun 1;93(21):7690-7698. doi: 10.1021/acs.analchem.1c00614. Epub 2021 May 19. 6.785
  3. Chen PK, Lan JL, Huang PH, Hsu JL, Chang CK, Tien N, Lin HJ, Chen DY. Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still’s Disease From COVID-19. Front Immunol 2021 Jul 23;12:719544. doi: 10.3389/fimmu.2021.719544. eCollection 2021. 7.624
  4. Su WY, Du PX, Santos HM, Ho TS, Keskin BB, Pau CH, Yang AM, Chou YY, Shih HC, Syu GD. Antibody Profiling in COVID-19 Patients with Different Severities by Using Spike Variant Protein Microarrays. Anal Chem. 2022 May 3;94(17):6529-6539. doi: 10.1021/acs.analchem.1c05567. Epub 2022 Apr 20 8.008.
  5. Huai-Chia Chuang, Chia-Hsin Hsueh, Pu-Ming Hsu, Rou-Huei Huang, Ching-Yi Tsai, Nai-Hsiang Chung, Yen-Hung Chow , Tse-Hua Tan. SARS-CoV-2 spike protein enhances MAP4K3/GLKinduced ACE2 stability in COVID-19. EMBO Mol Med. 2022 Sep 7;14(9):e15904. doi: 10.15252/emmm.202215904. Epub 2022 Jul 27. 14.300
  6. Wendimi Fatimata Belem, Ching-Hsuan Liu, Yee-Tung Hu, Thierry Burnouf, Liang-Tzung Lin. Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Viruses. 2022 Oct 31;14(11):2419. doi: 10.3390/v14112419. 5.818
  7. Po-Ku Chen, Kai-Jieh Yeo, Shih-Hsin Chang, Tsai-Ling Liao, Chia-Hui Chou, Joung-Liang Lan, Ching-Kun Chang, Der-Yuan Chen. The detectable anti-interferon-γ autoantibodies in COVID-19 patients may be associated with disease severity. Virol J. 2023 Feb 21;20(1):33. doi: 10.1186/s12985-023-01989-1. 5.916

Comments are closed.